Biotech · Private company
4D pharma plc
Track this companyFree. Adds 4D pharma plc to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- Avelumab 20 mg/mL Intravenous Solution (IV)Phase 2 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BlautixPhase 2 · Irritable Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- MRx0518Phase 2 · OncologyClinicalTrials.gov · fetched Nov 12, 2026
- MRx0518Phase 2 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Pembrolizumab 25 MG/1 ML Intravenous Solution [KEYTRUDA]Phase 2 · OncologyClinicalTrials.gov · fetched Nov 12, 2026
- Hypofractionated Preoperative RadiationPhase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- MRx-4DP0004Phase 1 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- MRx0518Phase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study of MRx0518 and Avelumab in Patients With Urothelial CarcinomaPHASE2 · WITHDRAWN · started Mar 1, 2022ClinicalTrials.gov NCT05107427 · fetched Nov 12, 2026
- A Study of Live Biotherapeutic Product MRx0518 With Hypofractionated Radiation Therapy in Resectable Pancreatic CancerPHASE1 · TERMINATED · started Dec 20, 2019ClinicalTrials.gov NCT04193904 · fetched Nov 12, 2026
- A Study of MRx-4DP0004 in AsthmaPHASE1 · TERMINATED · started Jul 4, 2019ClinicalTrials.gov NCT03851250 · fetched Nov 12, 2026
- Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid TumorsPHASE1_PHASE2 · TERMINATED · started Jan 10, 2019ClinicalTrials.gov NCT03637803 · fetched Nov 12, 2026
- A Trial for New Treatment of Adult Participants With Irritable Bowel SyndromePHASE2 · COMPLETED · started Oct 11, 2018ClinicalTrials.gov NCT03721107 · fetched Nov 12, 2026